98%
921
2 minutes
20
Most prior studies of cardiovascular disease (CVD) events have focused on incident events. Here, differences were analyzed by race/ethnicity in incident and recurrent CVD events in the Multi-Ethnic Study of Atherosclerosis from baseline in 2000-2002 through 2019 using joint and multivariable adjusted Cox proportional hazards modeling. Among 6814 men and women aged 45-85 years without known CVD at enrollment, during median follow-up of 17.7 years, 1206 incident and 695 recurrent CVD events occurred; 891 individuals with a nonfatal incident event were at risk for recurrent events. Rates of combined incident and recurrent CVD events among Black, White, Chinese, and Hispanic participants were 16.8, 18.6, 13.3, and 19.3 per 1000 person-years, respectively. First recurrent CVD event rates in Black, White, Chinese, and Hispanic participants were 87.7, 68.7, 78.1, and 80.7 per 1000 person-years, respectively. Revascularization rates were lower in Black compared with White participants (3.8 vs 6.4 per 1000 person-years; P < .0001). The adjusted hazard for CVD death was higher for Black than White participants (hazard ratio = 1.85; 95% CI, 1.03-3.29). In this multiethnic cohort, Black participants had a lower or similar rate of incident and recurrent CVD events, lower rate of revascularization, and higher rate of fatal CVD than did White participants.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342922 | PMC |
http://dx.doi.org/10.1093/aje/kwae399 | DOI Listing |
Int J Vitam Nutr Res
July 2025
Institute of Cardiovascular Disease, China Three Gorges University, 443005 Yichang, Hubei, China.
Background: The effects of dietary niacin on the risk of cardiovascular disease (CVD) and mortality in patients with chronic kidney disease (CKD) remain unclear.
Methods: CKD patients with estimated glomerular filtration rates (eGFRs) 20-59 mL/min/1.73 m or urinary albumin/creatinine ratio ≥30 mg/g were identified in the National Health and Nutrition Examination Survey (NHANES) data from 2003 to 2018.
Am J Prev Cardiol
September 2025
Department of Nutrition, School of Public Health, Guangzhou Medical University, Guangzhou, China.
Background: Evidence regarding the effect of physical activity (PA) on the risk of cardiovascular disease (CVD) among patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is scarce. We aimed to clarify the role of PA in preventing CVD in patients with MASLD and provide insights into PA recommendations specific to this patient group.
Methods: This study conducted two cohort studies of 112,872 subjects with MASLD using questionnaire-measured PA data and 22,426 subjects with MASLD using accelerometer-measured PA data.
Cureus
August 2025
Scientific Services, USV Private Limited, Mumbai, IND.
Background Medication adherence is mostly influenced by cost, and disease management can be achieved through cost-effective combinations. The present study aimed to evaluate adherence to the cost-effective fixed dose combination (FDC) of rosuvastatin and clopidogrel in the management of cardiovascular diseases (CVD). Methods This retrospective, non-randomized, non-comparative, multicenter study was conducted across 100 healthcare centers in India.
View Article and Find Full Text PDFJ Educ Health Promot
July 2025
Faculty of Health, York University, Toronto.
Background: Despite the benefits of cardiac rehabilitation (CR), women are under-represented, especially in lower-income settings. Technology may be leveraged to tailor CR to better engage women, but this has never been tested in a middle-income country. This study assessed the implementability, usability, engagement, and acceptability of Technology-bAsed Cardiac rehabilitation Therapy (TaCT) in women with cardiovascular disease (CVD) in a middle-income country.
View Article and Find Full Text PDFTob Induc Dis
September 2025
Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Introduction: The association between electronic cigarettes (e-cigarettes) and the risk of cardiovascular disease (CVD) remains inconclusive. This study aims to compare CVD risk from the use of e-cigarettes, cigarettes, combined cigarette and e-cigarette use, and non-use.
Methods: This study is a systematic review and network meta-analysis (NMA).